Literature DB >> 29312981

The day will come to treat HCC in a drugstore?

Kouichi Miura1.   

Abstract

Year:  2017        PMID: 29312981      PMCID: PMC5756762          DOI: 10.21037/hbsn.2017.07.09

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation.

Authors:  Yoshiyuki Goto; Casandra Panea; Gaku Nakato; Anna Cebula; Carolyn Lee; Marta Galan Diez; Terri M Laufer; Leszek Ignatowicz; Ivaylo I Ivanov
Journal:  Immunity       Date:  2014-03-27       Impact factor: 31.745

2.  A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.

Authors:  Stephan R Targan; Brian Feagan; Severine Vermeire; Remo Panaccione; Gil Y Melmed; Carol Landers; Dalin Li; Chris Russell; Richard Newmark; Nan Zhang; Yun Chon; Yi-Hsiang Hsu; Shao-Lee Lin; Paul Klekotka
Journal:  Am J Gastroenterol       Date:  2016-08-02       Impact factor: 10.864

3.  Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C.

Authors:  Chunqiu Hao; Yun Zhou; Yu He; Chao Fan; Li Sun; Xin Wei; Linxu Wang; Meijuan Peng; Pingzhong Wang; Jianqi Lian; Zhansheng Jia
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

4.  The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.

Authors:  Patrick M Smith; Michael R Howitt; Nicolai Panikov; Monia Michaud; Carey Ann Gallini; Mohammad Bohlooly-Y; Jonathan N Glickman; Wendy S Garrett
Journal:  Science       Date:  2013-07-04       Impact factor: 47.728

5.  Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients.

Authors:  Kun Li; Huaie Liu; Tao Guo
Journal:  Clin Res Hepatol Gastroenterol       Date:  2017-02-04       Impact factor: 2.947

6.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

Authors:  Dianne H Dapito; Ali Mencin; Geum-Youn Gwak; Jean-Philippe Pradere; Myoung-Kuk Jang; Ingmar Mederacke; Jorge M Caviglia; Hossein Khiabanian; Adebowale Adeyemi; Ramon Bataller; Jay H Lefkowitch; Maureen Bower; Richard Friedman; R Balfour Sartor; Raul Rabadan; Robert F Schwabe
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

7.  Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.

Authors:  Mitsuaki Ishioka; Kouichi Miura; Shinichiro Minami; Yoichiro Shimura; Hirohide Ohnishi
Journal:  Dig Dis Sci       Date:  2016-12-02       Impact factor: 3.199

8.  Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice.

Authors:  Jun Li; Cecilia Ying Ju Sung; Nikki Lee; Yueqiong Ni; Jussi Pihlajamäki; Gianni Panagiotou; Hani El-Nezami
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

Review 9.  Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.

Authors:  Yan-Yan Ma; Lin Li; Chao-Hui Yu; Zhe Shen; Li-Hua Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

10.  Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma.

Authors:  Ana L Gomes; Ana Teijeiro; Stefan Burén; Krishna S Tummala; Mahmut Yilmaz; Ari Waisman; Jean-Philippe Theurillat; Cristian Perna; Nabil Djouder
Journal:  Cancer Cell       Date:  2016-07-11       Impact factor: 31.743

View more
  3 in total

1.  The role of exosomes in tumor immunity.

Authors:  Huayu Yang; Lejia Sun; Yilei Mao
Journal:  Ann Transl Med       Date:  2018-12

2.  CMTTdb: the cancer molecular targeted therapy database.

Authors:  Xue Bai; Xiaobo Yang; Liangcai Wu; Bangyou Zuo; Jianzhen Lin; Shanshan Wang; Jin Bian; Xinting Sang; Yungang He; Zhen Yang; Haitao Zhao
Journal:  Ann Transl Med       Date:  2019-11

3.  Differentially expressed liver exosome-related genes as candidate prognostic biomarkers for hepatocellular carcinoma.

Authors:  Bangyou Zuo; Jing Kuai; Junyu Long; Jin Bian; Xu Yang; Xiaobo Yang; Ziyu Xun; Yiran Li; Huishan Sun; Xinting Sang; Haitao Zhao
Journal:  Ann Transl Med       Date:  2022-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.